|
 放射性化合物
 伯森在台獨家代理國際知名品牌 PerkinElmer 與 Moravek Biochemicals 之放射性產品，品項豐富齊全。其中由 PerkinElmer 所出品的 NEN® 放射性產品，已具有超過 50 年以上的生產製造經驗，品質有口皆碑！各種常用品項已為您整理分類於下表中，若您無法找尋到需要的產品，歡迎多加利用便利的伯森客戶服務資源 02-2788-2121 / 0800-059-668 / 線上留言，我們將協助您快速取得適用產品資訊。
- 放射性標定核苷酸
- 35S 標定胺基酸
- 125I 標定產物
- 3H 標定產物
- 14C 標定產品
- 放射性核種
Radioactive Nucleotides
| Product |
Specific Acticity |
Concentration |
Cat. No. |
| |
[Ci/mmol] |
[mCi/mL] |
[μM] |
EasyTide, ready to use
Shipped ambient, store at 2~8℃ |
Shipped in dry ice, stored at -20℃ |
| 32P-Labeled Nucelotides |
| ATP, [α-32P]- |
800
3000 |
10
10 |
12.5
3.3 |
—
PK-BLU503H / PK-NEG003H |
PK-BLU003X / PK-NEG003X
PK-BLU003H / PK-NEG003H |
| CTP, [α-32P]- |
800
3000 |
10
10 |
12.5
3.3 |
PK-BLU508X / PK-NEG508X
PK-BLU508H / PK-NEG508H |
PK-BLU008X / PK-NEG008X
PK-BLU008H / PK-NEG008H |
| GTP, [α-32P]- |
800
3000 |
10
10 |
12.5
3.3 |
—
PK-BLU506H / PK-NEG506H |
PK-BLU006X / PK-NEG006X
PK-BLU006H / PK-NEG006H |
| UTP, [α-32P]- |
800
800
800
3000
6000 |
10
20
40
10
40 |
12.5
25
50
3.3
6.7 |
PK-BLU507X / PK-NEG507X
PK-BLU507T / PK-NEG507T
PK-BLU507C / PK-NEG507C
PK-BLU507H / PK-NEG507H
PK-BLU507Z / PK-NEG507Z |
PK-BLU007X / PK-NEG007X
—
PK-BLU007C / PK-NEG007C
PK-BLU007H / PK-NEG007H
PK-BLU007Z / PK-NEG007Z |
| dATP, [α-32P]- |
800
3000
6000 |
10
10
20 |
12.5
3.3
3.3 |
PK-BLU512A / PK-NEG512A
PK-BLU512H / PK-NEG512H
PK-BLU512Z / PK-NEG512Z |
—
PK-BLU012H / PK-NEG012H
PK-BLU012Z / PK-NEG012Z |
| dCTP, [α-32P]- |
800
3000
6000 |
10
10
20 |
12.5
3.3
3.3 |
PK-BLU513A / PK-NEG513A
PK-BLU513H / PK-NEG513H
PK-BLU513Z / PK-NEG513Z |
PK-BLU013A / PK-NEG013A
PK-BLU013H / PK-NEG013H
PK-BLU013Z / PK-NEG013Z |
| dGTP, [α-32P]- |
3000
6000 |
10
20 |
3.3
3.3 |
PK-BLU514H / PK-NEG514H
PK-BLU514Z / PK-NEG514Z |
—
PK-BLU014Z / PK-NEG014Z |
| dTTP, [α-32P]- |
800
3000 |
10
10 |
12.5
3.3 |
PK-BLU505A / PK-NEG505A
PK-BLU505H / PK-NEG505H |
PK-BLU005A / PK-NEG005A
PK-BLU005H / PK-NEG005H |
| 3’dATP, [α-32P]- |
5000 |
10 |
2 |
— |
PK-BLU026 / PK-NEG026 |
| ATP, [γ-32P]- |
10
3000
3000
6000
6000 |
2
5
10
10
150 |
200
1.7
3.3
1.7
25 |
—
PK-BLU502H / PK-NEG502H
PK-BLU502A / PK-NEG502A
PK-BLU502Z / PK-NEG502Z
— |
PK-BLU002 / PK-NEG002
PK-BLU002H / PK-NEG002H
PK-BLU002A / PK-NEG002A
PK-BLU002Z / PK-NEG002Z
PK-NEG035C |
| GTP, [γ-32P]- |
6000 |
10 |
1.7 |
PK-BLU504Z / PK-NEG504Z |
PK-BLU004Z / PK-NEG004Z |
| NAD, [32P]- |
800 |
5 |
6.3 |
— |
PK-BLU023X / PK-NEG023X |
| pCp, [5’-32P]- |
3000 |
10 |
3.3 |
— |
PK-BLU019A / PK-NEG019A |
| 33P-Labeled Nucelotides |
| ATP, [α-33P]- |
3000 |
10 |
3.3 |
PK-NEG603H |
— |
| CTP, [α-33P]- |
3000 |
10 |
3.3 |
PK-NEG608H |
— |
| GTP, [α-33P]- |
3000 |
10 |
3.3 |
PK-NEG606H |
— |
| UTP, [α-33P]- |
3000 |
10 |
3.3 |
PK-NEG607H |
PK-NEG307H |
| dATP, [α-33P]- |
3000 |
10 |
3.3 |
PK-NEG612H |
PK-NEG312H |
| dCTP, [α-33P]- |
3000 |
10 |
3.3 |
PK-NEG613H |
PK-NEG313H |
| dTTP, [α-33P]- |
3000 |
10 |
3.3 |
PK-NEG605H |
— |
| ATP, [γ-33P]- |
3000
3000 |
10
10 |
3.3
3.3 |
PK-NEG602H
PK-NEG602K |
PK-NEG302H
— |
| GTP, [γ-33P]- |
3000 |
10 |
3.3 |
PK-NEG604H |
— |
| 2-Methylthio ADP, [β-33P] |
3000 |
2 |
3.3 |
— |
PK-NEG380H |
| 35S-Labeled Nucelotides |
| ATPαS, [35S]- |
1250 |
12.5 |
10 |
— |
PK-NEG033H |
| CTPαS, [35S]- |
1250
1250 |
12.5
70 |
10
56 |
—
— |
PK-NEG064H
PK-NEG064C |
| UTPαS, [35S]- |
800
1250 |
40
12.5 |
50
10 |
—
PK-NEG739H |
PK-NEG039C
PK-NEG039H |
| dATPαS, [35S]- |
500
1250 |
10
12.5 |
20
10 |
—
PK-NEG734H |
PK-NEG034S
PK-NEG034H |
| ATPγS, [35S]- |
25–100
1250 |
12.5
12.5 |
125–500
10 |
—
— |
PK-NEG027
PK-NEG027H |
| GTPγS, [35S]- |
1250
1250 |
12.5
12.5 |
10
10 |
—
— |
PK-NEG030H
PK-NEG030X |
| PAPS 3’, [35S]- |
1–3 |
0.5 |
167–500 |
— |
PK-NEG010 |
|
|
35S-Labeled Amino Acids
| Product |
Specific Activity [Ci/mmol] |
Activity Concentration [mCi/ml] |
Cat. No. |
Cysteine, L-[35S]-
Packaged in 10 mM DTT. |
>1000 |
11 |
PK-NEG022T |
EXPRE35S35S Protein Labeling Mix, [35S]-, (EasyTag™)
A mixture of approximately 73% [35S]-methionine and 22% L-[35S]-cysteine prepared directly from the hydrolysate of E. coli grown in the presence of carrier-free 35SO4 with added stabilizer. Packaged in a stabilized aqueous solution. |
>1000 |
11 |
PK-NEG772 |
EXPRE35S35S Protein Labeling Mix, [35S]-
A mixture of approximately 73% [35S]-methionine and 22% L-[35S]-cysteine prepared directly from the hydrolysate of E. coli grown in the presence of carrier-free 35SO4. Packaged in 50 mM tricine (pH 7.4) and 10 mM 2-mercaptoethanol. |
>1000 |
11 |
PK-NEG072 |
Methionine, L-[35S]-
Cell Labeling Grade
Packaged in 10 mM 2-mercaptoethanol. |
>600 |
31.5 |
PK-NEG009L |
Methionine, L-[35S]-
Packaged in 10 mM 2-mercaptoethanol. |
>800 |
11 |
PK-NEG009H |
Methionine, L-[35S]-, (EasyTag)
Packaged in a stabilized aqueous solution with blue dye. |
>1000 |
10.2 |
PK-NEG709A |
Methionine, L-[35S]-
Packaged in 50 mM tricine (pH 7.4) and 10 mM 2-mercaptoethanol. |
>1000 |
10.2 |
PK-NEG009A |
Methionine, L-[35S]-
Packaged in 10 mM 2-mercaptoethanol. |
>1000 |
11 |
PK-NEG009T |
Methionine, L-[35S]-
Packaged in 50 mM tricine (pH 7.4) and 10 mM 2-mercaptoethanol. |
>1000 |
43.3 |
PK-NEG009C |
|
125I Labeled Products
| Product |
Cat. No. |
| A-85380, [125I]- |
PK-NEX413 |
| AB-MECA, [125I]-, (4-amino-3-[125I]iodobenzyl-5’-N-) |
PK-NEX312 |
| ACTH, (1-39) Tyr2-[125I]- |
PK-NEX342 |
| ACTH, (1-39) Tyr23-[125I]- |
PK-NEX165 |
| Adenosine 3’,5’-cyclic phosphoric acid, 2’-O-succinyl [125I]-iodotyrosine methyl ester |
PK-NEX130 |
| Adrenomedullin, [125I]Tyr-, (human, 13–52) |
PK-NEX385 |
| Adrenomedullin (Rat), [125I]- |
PK-NEX427 |
| AGRP (Ac-87-132), [125I]-, (human, synthetic) |
PK-NEX372 |
| Albumin, Bovine Serum, [125I]-, ([125I]-BSA) |
PK-NEX076 |
| Aminopotentidine, [125I] |
PK-NEX431 |
| Amylin, [125I]-, (rat) |
PK-NEX448 |
| Angiotensin I (Tyr4), [125I]-, (human) |
PK-NEX101 |
| Angiotensin II (Sar1,Tyr4, Ile8), [125I]- |
PK-NEX248 |
| Angiotensin II (Tyr4), [125I]-, (human) |
PK-NEX105 |
| Angiotensin IV (Tyr2), [125I]-, (human) |
PK-NEX295 |
| Anti-mouse IgG, whole antibody, [125I]-, (goat) |
PK-NEX159 |
| Anti-rabbit IgG, whole antibody, [125I]-, (goat) |
PK-NEX155 |
| Antisauvagine-30 (8-1-His2), [(125I)]- |
PK-NEX399 |
| Apamin (His18-NH2), [125I]- |
PK-NEX242 |
| Apelin 13 (Glp65, Nle75, Tyr7), [125I]- |
PK-NEX393 |
| Atrial Natriuretic Factor - Tyr28 (rat) - [125I]-ANF |
PK-NEX228 |
| α- Atrial Natriuretic Peptide - Tyr28 (human) [125I] α-ANP |
PK-NEX425 |
| BeKm-1 (Tyr11), [125I]- |
PK-NEX412 |
| Bolton-Hunter Reagent, [125I]-, (monoiodinated) |
PK-NEX120 |
| Bolton-Hunter Reagent, [125I]-, (diiodinated) |
PK-NEX120H |
| Bombesin (D-Tyr6 , βAla11, Phe13, Nle14), [125I]-, (6–14) |
PK-NEX377 |
| Bombesin (Tyr4), [125I]- |
PK-NEX258 |
| α-Bungarotoxin (Tyr54), [125I]- |
PK-NEX126
PK-NEX126H |
| Calcitonin Gene-Related Peptide, [125I]-, ([125I]-hCGRP), (human) |
PK-NEX354 |
| Calcitonin [Tyr12] (Human), [125I] |
PK-NEX422 |
| Calcitonin Gene-Related Peptide,- 2-[125I]-iodohistidyl10,(human) Receptor Grade |
PK-NEX442 |
| Calcitonin[Tyr22] (Salmon), [125I] |
PK-NEX423 |
| CCL15, [125I]-, (human, recombinant) |
PK-NEX401 |
| CGP 42112A, [125I]- |
PK-NEX324 |
| Cholecystokinin Octapeptide, [125I]-, Bolton-Hunter labeled, ([125I]-CCK-8) |
PK-NEX203 |
| Chorionic Gonadotropin [125I], ([125I]-hCG), (human) |
PK-NEX106 |
| 6-Ckine, [125I]-, Bolton-Hunter labeled, (CCL21), (human, recombinant) |
PK-NEX387 |
| Complement C3a, [125I]-, Bolton-Hunter labeled, (human) |
PK-NEX356 |
| Complement C5a, [125I]-, Bolton-Hunter labeled, (human, recombinant) |
PK-NEX250 |
| ω-Conotoxin GVIA (Tyr22), [125I]- |
PK-NEX239 |
| ω-Conotoxin MVIIC, [125I]- |
PK-NEX323 |
| Corticotropin Releasing Factor (Tyr0), [125I]-, (ovine) |
PK-NEX217 |
| Corticotropin Releasing Factor (Tyr0), [125I]-, (human, rat) |
PK-NEX216 |
| Cortisol-3-(0-carboxymethyl)oximino-(2-[125I], iodohistamine) |
PK-NEX435 |
| CTACK, [125I]-, (CCL27), (human, recombinant) |
PK-NEX391 |
| CXCL16, [125I]-, (human, recombinant) |
PK-NEX398 |
| (-)-Cyanopindolol, [125I]iodo- |
PK-NEX189 |
| (±)-Cyanopindolol, [125I]iodo- |
PK-NEX174 |
| Dendrotoxin-a-[125I] |
PK-NEX434 |
| 2’-Deoxycytidine-5’-triphosphate, tetraammonium salt, 5-[125I]iodo- |
PK-NEX074 |
| (±)-DOI, [125I]- |
PK-NEX255 |
| Echistatin [125I] - |
PK-NEX439 |
| Eledoisin (Lys4), [125I]-, Bolton-Hunter labeled |
PK-NEX218 |
| Endothelin-1 (Tyr13), [125I]-, ([125I]-ET-1), (human, porcine) |
PK-NEX259 |
| Eotaxin, [125I]-, (human, recombinant) |
PK-NEX314 |
| Epibatidine, [125I]-, ([125I]-IPH) |
PK-NEX358 |
| Epidermal Growth Factor, [125I]- (human, recombinant) |
PK-NEX428 |
| Epidermal Growth Factor, [125I]-, ([125I]-EGF), (murine) |
PK-NEX160 |
| Estradiol-6-(0-carboxymethyl)oximino-(2-[125I], iodohistamine) |
PK-NEX438 |
| 3,17β-Estradiol, 16a-[125I]iodo- |
PK-NEX144
PK-NEX144L |
| Exendin, [125I]-, (9–39) |
PK-NEX335 |
| Fibrinogen (Human), [125I] |
PK-NEX430 |
| Fibroblast Growth Factor Basic, [125I]-, ([125I]-FGF basic), (human, recombinant) |
PK-NEX268 |
| Follicle Stimulating Hormone, [125I]-, ([125I]-FSH) |
PK-NEX173 |
| Fractalkine, [125I]-, (human, recombinant) |
PK-NEX368 |
| Galanin, [125I]-, (2–11) |
PK-NEX416 |
| Galanin, [125I]-, (human) |
PK-NEX333 |
| Galanin, [125I]-, (porcine) |
PK-NEX243 |
| Gastric Inhibitory Polypeptide, [125I]-, (human) |
PK-NEX402 |
| Gastrin Releasing Peptide (porcine), [125I-Tyr15]-[125I]-GRP(p) |
PK-NEX421 |
| Gastrin I (Tyr12), [125I]-, (human) |
PK-NEX176 |
| Ghrelin (His), [125I]-, (human) |
PK-NEX388 |
| Glucagon-like Peptide-1, [125I]-, ([125I]-GLP-1), (7–36) |
PK-NEX308 |
| Glucagon-like Peptide-2, [125I]-, ([125I]-GLP-2) |
PK-NEX390 |
| Glucagon, [125I]-, receptor grade |
PK-NEX207 |
| Granulocyte Macrophage-Colony Stimulating Factor, [125I]-, |
PK-NEX249 |
| GRO Alpha/MGSA, [125I]- |
PK-NEX321 |
| Growth Hormone, [125I]-, ([125I]-hGH), (human) |
PK-NEX100 |
| Guanosine 3’,5’-cyclic phosphoric acid, 2’-O-succinyl, [125I]-iodotyrosine, methyl ester |
PK-NEX131 |
| HEAT, [125I]- |
PK-NEX182 |
| Hemokinin-1, [125I]-, Bolton-Hunter labeled |
PK-NEX414 |
| I309, [125I]-, Bolton-Hunter labeled, (human, recombinant) |
PK-NEX364 |
| INSL-3, [125I]- |
PK-NEX419 |
| Insulin, [125I]-(human, recombinant) |
PK-NEX420 |
| Insulin, [125I]-, (porcine) |
PK-NEX104 |
| Insulin, (TyrA14), [125I]-, receptor grade, (porcine) |
PK-NEX196 |
| Insulin-like Growth Factor-I, [125I]-, ([125I]-IGF-I), (human, recombinant) |
PK-NEX241 |
| Insulin-like Growth Factor ll (human, recombinant), [125I] |
PK-NEX429 |
| Interleukin-1β, [125I]-, ([125I]-IL-1β), (human, recombinant) |
PK-NEX232 |
| Interleukin-2, [125I]-, ([125I]-IL-2), (human, recombinant) |
PK-NEX229 |
| Interleukin-6, [125I]-, ([125I]-IL-6), (human, recombinant) |
PK-NEX269 |
| Interleukin-8, [125I]-, ([125I]-IL-8), (human, recombinant) |
PK-NEX277 |
| Interleukin-8 (IL-8), [125I]-, (human, recombinant) receptor grade |
PK-NEX443 |
| Iodoclonidine, p-[125I]-, (2-(2,6-dichloro-4)-[125I]-) |
PK-NEX253 |
| Iododeoxyuridine, 5-[125I]- |
PK-NEX072 |
| Iodoproxyfan-[125I] |
PK-NEX436 |
| Iodosulpride-[125I], (dopamine D2 antagonist) |
PK-NEX441 |
| IP-10, [125I]-, Bolton-Hunter labeled, (human, recombinant) |
PK-NEX348 |
| I-TAC, [125I]-, (human, recombinant) |
PK-NEX376 |
| JE, [125I]-, Bolton-Hunter labeled, (MCP-1, murine, recombinant) |
PK-NEX313 |
| Leptin, [125I]-, (human, recombinant) |
PK-NEX347 |
| Leptin, [125I]-, (murine, recombinant) |
PK-NEX340 |
| Luteinizing Hormone Releasing Hormone (D-Trp6), [125I]-, ([125I]-LH-RH) |
PK-NEX365 |
| Luteinizing Hormone Releasing Hormone (Tyr5), [125I]-, ([125I]-LH-RH) |
PK-NEX163 |
| (+)-Lysergic Acid Diethylamide, 2-[125I]iodo-, ([125I]-LSD) |
PK-NEX199 |
| Mamba Intestinal Toxin-1, [125I]-Bolton-Hunter labeled [125I]-MIT-1 |
PK-NEX414 |
| Melanin Melanin Concentrating Hormone (Phe13, Tyr19), [125I]-, (Phe13[125I]Tyr19-MCH), (human, mouse, rat) |
PK-NEX375 |
| Melanin Concentrating Hormone, [125I]-, ([125I]-MCH), (human) |
PK-NEX373 |
| Melanin Concentrating Hormone-1 Receptor antagonist, [125I]-, ([125I]-hMCH-1R), (human) |
PK-NEX406 |
| Melatonin, 2-[125I]iodo- |
PK-NEX236 |
| Metastin, [125I]-, (45–54) |
PK-NEX395 |
| Monocyte Chemoattractant Protein-1 [125I], Bolton-Hunter labeled, ([125I]-MCP-1), (human, recombinant) |
PK-NEX332 |
| MIP-1α, [125I]-, (human, recombinant) |
PK-NEX298 |
| MIP-1β (Leu3, Gly47), [125I]-, (human, recombinant) |
PK-NEX299 |
| MIP-3α, [125I]-, (human, recombinant) |
PK-NEX371 |
| MIP-3β, [125I]-, (human, recombinant) |
PK-NEX370 |
| MIT-1, [125I]-, Bolton-Hunter labeled |
PK-NEX410 |
| Motilin, [125I]- |
PK-NEX378 |
| α-MSH (Nle4, D-Phe7), [125I]- |
PK-NEX352 |
| MT II (His), [125I]- |
PK-NEX374 |
| β-Nerve Growth Factor, [125I]-, (human, recombinant) |
PK-NEX440 |
| Neurokinin A, [125I]-, ([125I]-Substance K, [125I]-NKA) |
PK-NEX252 |
| Neurokinin B (MePhe7) His, [125I]-, ([125I]-NKB) |
PK-NEX285 |
| Neuromedin U-25 (Tyr18), [125I]-, ([125I]-NMU-25), (porcine) |
PK-NEX383 |
| Neuromedin U-8, [125I]-, ([125I]-NMU-8) |
PK-NEX392 |
| Neuropeptide B23 (Des-Br), [125I]-, ([125I]-NPB23), (human) |
PK-NEX405 |
| Neuropeptide FF (D-Tyr1, N-MePhe3), [125I]-, ([125I]-NPFF) |
PK-NEX381 |
| Neuropeptide S (Tyr10), [125I]-, ([125I]-NPS), (human) |
PK-NEX411 |
| Neuropeptide W23, [125I]-, ([125I]-NPW23), (human) |
PK-NEX403 |
| Neuropeptide Y (Lys4), [125I]-Bolton Hunter labeled, [125I]-NPY, (porcine) |
PK-NEX222 |
| Neurotensin (Tyr3), [125I]- |
PK-NEX198 |
| Nociceptin (Tyr14), [125I]- |
PK-NEX338 |
| Orexin A, [125I]- |
PK-NEX367 |
| Ornithine Vasotocin Analog, [125I]-, ([125I]-OVTA) |
PK-NEX254 |
| Oxytocin (Tyr2), [125I]- |
PK-NEX187 |
| PACAP 27, [125I]- |
PK-NEX294 |
| PDGF-BB (h,r), [125I] |
PK-NEX433 |
| Pancreatic Polypeptide, [125I]-, (human) |
PK-NEX315 |
| Parathyroid Hormone (Nle8,18, Tyr34), [125I]-, ([125I]-PTH), (human, 1–34) |
PK-NEX397 |
| Parathyroid Hormone amide (Nle8,21, Tyr34), [125I]-, ([125I]-PTH amide), (rat, 1–34) |
PK-NEX353 |
| Peptide YY (Leu31, Pro34), [125I]-, ([125I]-PYY), (porcine) |
PK-NEX334 |
| Peptide YY, [125I]-, ([125I]-PYY), (human) |
PK-NEX341 |
| Peptide YY, [125I]-, ([125I]-PYY), (porcine) |
PK-NEX240 |
| (-)-Pindolol, [125I]iodo- |
PK-NEX211 |
| R (+) trans-7-hydroxy-PIPAT, [125I]- |
PK-NEX307 |
| Prazosin Analog, [125I]iodoazido-, (Iodoarylazidoprazosin) |
PK-NEX219 |
| Prolactin, [125I]-, (rat) |
PK-NEX108 |
| Protein A, [125I]-, (human, recombinant) |
PK-NEX146
PK-NEX146L |
| Protein G, [125I]-, Bolton-Hunter labeled, (human, recombinant) |
PK-NEX237 |
| ProTx-II, [125I]-, (tarantula) |
PK-NEX450 |
| QRFP-43, [125I]-, (human) |
PK-NEX408 |
| RANTES, [125I]-, (human, recombinant) |
PK-NEX292 |
| H2 Relaxin, [125I]-, Bolton-Hunter labeled |
PK-NEX409 |
| H3 Relaxin, [125I]- |
PK-NEX418 |
| Resiniferatoxin, [125I]- |
PK-NEX394 |
| RTI-121, [125I]- |
PK-NEX318 |
| RTI-55, [125I]- |
PK-NEX272 |
| S36057 (Tyr), [125I]- |
PK-NEX396 |
| SB258585, [125I] |
PK-NEX424 |
| Sauvagine (Tyr0), [125I]- |
PK-NEX306 |
| SDF-1α, [125I]-, (human, recombinant) |
PK-NEX346 |
| SHU9119, [125I]- |
PK-NEX362 |
| Somatostatin-14 (Tyr11), [125I]- |
PK-NEX389 |
| Somatostatin-14 (Tyr11), [125I]-, (human, recombinant) receptor grade |
PK-NEX446 |
| Somatostatin-28, [125I] |
PK-NEX447 |
| 2’-Spiperone, [125I]iodo- |
PK-NEX284 |
| Streptavidin, [125I]- |
PK-NEX238 |
| Substance P (Lys3), [125I]-, Bolton-Hunter labeled |
PK-NEX190 |
| Substance P (Tyr8), [125I]- |
PK-NEX152 |
| TARC, [125I]-, (human, recombinant) |
PK-NEX369 |
| Thyrotropin Releasing Hormone (His2), [125I]-, ([125I]-TRH) |
PK-NEX153 |
| Thyroxine, L-, [125I]-, ([125I]-T4) |
PK-NEX111 |
| Transferrin, [125I]-, diferric, (human) |
PK-NEX212 |
| Transforming Growth Factor β-1, [125I]-, ([125I]-TGF-β1), (human, recombinant) |
PK-NEX267 |
| Triiodothyronine, L-3,3’,5’-[125I]-, ([125I]-Reverse T3) |
PK-NEX109 |
| Triiodothyronine, L-3,5,3’-[125I]-, ([125I]-T3) |
PK-NEX110
PK-NEX110H
PK-NEX110X |
| Tumor Necrosis Factor-α, [125I]-, ([125I]-rTNFα), (human, recombinant) |
PK-NEX257 |
| Ubiquitin, [125I]- |
PK-NEX404 |
| Urotensin II (Tyr9), [125I]-, (human) |
PK-NEX379 |
| Vascular Endothelial Growth Factor, [125I]-, ([125I]-VEGF), (human, recombinant) |
PK-NEX328 |
| Vasoactive Intestinal Polypeptide, [125I]-, ([125I]-VIP), (human, porcine, rat) |
PK-NEX192 |
| Vasopressin (linear), V1A antagonist (phenylacetyl1, 0-Me-D-Tyr2, Arg6,8, Tyr9), [125I]- |
PK-NEX310 |
| Vasopressin (Tyr2, Arg8), [125I]- |
PK-NEX128 |
| WKYMVm, [125I]-, Bolton-Hunter labeled |
PK-NEX386 |
|
3H-Labeled Amino Acids
| Product |
Molecular Formula & Labeling Position(s) |
Specific Activity [Ci/mmol] |
Activity Conc. [mCi/ml] |
Cat. No. |
| Alanine, L-[3-3H]- |
CH3CH(NH2)CO2H |
65–85 |
1 |
PK-NET348 |
| Arginine monohydrochloride, L-[2,3,4-3H]- |
H2NC(NH)NH(CH2)3CH(NH2)CO2H.HCl |
40–70 |
1 |
PK-NET1123 |
| Aspartic acid, D-[2,3-3H]- |
HO2CCH2CH(NH2)CO2H |
10–25 |
1 |
PK-NET581 |
| Glutamic acid, L-[3,4-3H]- |
HO2C(CH2)2CH(NH2)CO2H |
40–80 |
1 |
PK-NET490 |
| Glutamine, L-[3,4-3H(N)]- |
H2NCO(CH2)2CHCNH2CO2H |
30–60 |
1 |
PK-NET551 |
| Glycine, [2-3H]- |
H2NCH2CO2H |
30–60 |
1 |
PK-NET004 |
| Leucine, L-[3,4,5-3H(N)]- |
(CH3)2CHCH2CH(NH2)CO2H |
100–150 |
1 |
PK-NET460 |
| Leucine, L-[3,4,5-3H(N)]- |
(CH3)2CHCH2CH(NH2)CO2H |
100–150 |
5 |
PK-NET460A |
| Leucine, L-[4,5-3H(N)]- |
(CH3)2CHCH2CH(NH2)CO2H |
40–60 |
1 |
PK-NET135H |
| Lysine, L-[4,5-3H(N)]- |
H2NCH2CH2CH2CH2CH(NH2)CO2H.HCl |
80–110 |
1 |
PK-NET376 |
| Methionine, L-[methyl-3H]- |
CH3S(CH2)2CH(NH2)CO2H |
70–85 |
1 |
PK-NET061X |
| Proline, L-[2,3-3H]- |
HNCH2CH2CH2CHCO2H |
25–55 |
1 |
PK-NET323 |
| Proline, L-[2,3,4,5-3H]- |
HNCH2CH2CH2CHCO2H |
>75 |
1 |
PK-NET483 |
| Proline, L-[2,3,4,5-3H]- |
HNCH2CH2CH2CHCO2H |
85-130 |
5 |
PK-NET483V |
| Serine, L-[3H(G)]- |
HOCH2CH(NH2)CO2H |
15–40 |
1 |
PK-NET248 |
| Tyrosine, L-[ring-3,5-3H]- |
p-HOC6H4CH2CH(NH2)CO2H |
40–60 |
1 |
PK-NET127 |
|
| |
3H-Labeled Thymidines
| Product |
Specific Activity [Ci/mmol] |
Activity Conc. [mCi/ml] |
Cat. No. |
| To study DNA proliferation rates |
Thymidine, [methyl-3H]-
Steri-packaged in an aqueous solution.
Not for human use. |
2 |
1 |
PK-NET027A |
Thymidine, [methyl-3H]-
Steri-packaged in an aqueous solution.
Not for human use. |
6.7 |
1 |
PK-NET027 |
Thymidine, [methyl-3H]-
Packaged in ethanol:water (7:3).
Not for human use |
20 |
1 |
PK-NET027E |
Thymidine, [methyl-3H]-
Steri-packaged in ethanol:water (2:98).
Not for human use |
23–27 |
1 |
PK-NET027L |
Thymidine, [methyl-3H]-
Steri-packaged in ethanol:water (2:98).
Not for human use |
40–60 |
1 |
PK-NET027W |
Thymidine, [methyl-3H]-
Steri-packaged in an aqueous solution.
Not for human use. |
20 |
1 |
PK-NET027X |
Thymidine, [methyl-3H]-
Steri-packaged in an aqueous solution.
Not for human use. |
70–90 |
1 |
PK-NET027Z |
| To study total nucleic acid proliferation rates |
Thymidine, [6-3H]-
Steri-packaged in an aqueous solution.
Not for human use. |
>10 |
1 |
PK-NET355 |
| For DNA probe labeling |
Deoxythymidine 5’-triphosphate, tetrasodium salt, [methyl-3H]-,
Packaged in ethanol:water (1:1). |
10–25 |
1 |
PK-NET221H |
Deoxythymidine 5’-triphosphate, tetrasodium salt, [methyl-3H]-
Packaged in ethanol:water (1:1). |
70–90 |
1 |
PK-NET221X |
Deoxythymidine 5’-triphosphate, tetrasodium salt, [methyl-3H]-
Packaged in 10 mM tricine (pH 7.6). |
70–90 |
2.5 |
PK-NET221A |
Deoxythymidine 5’-triphosphate, tetrasodium salt, [methyl, 1’,2’-3H]
Packaged in 10 mM tricine (pH 7.6). |
90–120 |
2.5 |
PK-NET520A |
|
14C-Labeled Amino Acids
| Product |
Molecular Formula & Labeling Position(s) |
Specific Activity [Ci/mmol] |
Activity Conc. [mCi/ml] |
Cat. No. |
| Alanine, L-[14C(U)]- |
CH3CH(NH2)CO2H |
>150 |
0.1 |
PK-NEC266E |
| Arginine L-[14C(U)]- |
H2NC(NH)NH(CH2)3CH(NH2)CO2H.HCl |
>300 |
0.1 |
PK-NEC267E |
| Cystine L-[14C(U)]- |
(HO2CCH(NH2)CH2S)2 |
>250 |
0.02 |
PK-NEC465 |
| Glutamic Acid, L-[14C(U)]- |
HO2C(CH2)2CH(NH2)CO2H |
>250 |
0.1 |
PK-NEC290E |
| Glycine, [14C(U)]- |
H2NCH2CO2H |
>100 |
0.1 |
PK-NEC276E |
| Isoleucine, L-[14C(U)]- |
CH3CH2CH(CH3)CH(NH2)CO2H |
>300 |
0.05 |
PK-NEC278E |
| Leucine, L-[14C(U)]- |
(CH3)2CHCH2CH(NH2)CO2H |
>300 |
0.1 |
PK-NEC279E |
| Lysine, L-[14C(U)]- |
H2NCH2(CH2)3CH(NH2)CO2H.HCl |
>300 |
0.1 |
PK-NEC280E |
| Phenylalanine, L-[14C(U)]- |
C6H5CH2CH(NH2)CO2H |
>450 |
0.1 |
PK-NEC284E |
| Proline, L-[14C(U)]- |
HN2H2CH2CH2CHCO2H |
>250 |
0.1 |
PK-NEC285E |
| Serine, L-[14C(U)]- |
HOCH2CH(NH2)CO2H |
>150 |
0.1 |
PK-NEC286E |
| Serine, L-[3- 14C]- |
HOCH2(NH2)CO2H |
50-62 |
0.05 |
PK-NEC827 |
| Tyrosine L-[14C(U)]- |
HOPHCH2CH(NH2)CO2H |
>450 |
0.05 |
PK-NEC289E |
L-Amino acid mixture, [14C(U)]-
A mixture of L-Ala, L-Arg, L-Asp, L-Glu, Gly, L-His, L-Ile, L-Leu, L-Lys, L-Phe, L-Pro, L-Ser, L-Thr, L-Tyr and L-Val |
N/A |
N/A |
0.1 |
PK-NEC445E |
|
| |
14C-Labeled Thymidines
| Product |
Specific Activity [mCi/mmol] |
Activity Conc. [mCi/ml] |
Cat. No. |
| To study DNA proliferation rates |
Thymidine, [methyl-14C]-
Steri-packaged in an aqueous solution.
Not for human use. |
40–60 |
0.1 |
PK-NEC568 |
Thymidine, [methyl-14C]-
Steri-packaged in aquesous solution
Not for human use |
50-62 |
1 |
PK-NEC568D |
| To study total nucleic acid proliferation rates |
Thymidine, [2-14C]-
Steri-packaged in an aqueous solution.
Not for human use. |
>50 |
0.1 |
PK-NEC156 |
|
Radionuclides
| Radionuclide |
Packaging & Form |
Specific Activity |
Fresh Lot Availability |
Cat. No. |
Calcium-45
Symbol: 45Ca
Half Life: 163 d
Radiation Type: beta
|
As calcium chloride in aqueous solution |
>10 Ci/g |
Every 4 weeks |
PK-NEZ013 |
Chromium-51
Symbol: 51Cr
Half Life: 27.7 d
Radiation Type: gamma |
As chromium chloride in 0.5 M HCl.
|
>50 Ci/g |
Every 4 weeks |
PK-NEZ020
|
| As sodium chromate in normal saline (pH 8–10). Steri-packaged; not for human use. 5mci/ml |
400–1200 Ci/g |
Every 4 weeks |
PK-NEZ030 |
| As sodium chromate in normal saline (pH 8–10). Steri-packaged; not for human use. 1mci/ml |
400–1200 Ci/g |
Every 4 weeks |
PK-NEZ030S |
| As EDTA complex in 0.005 M EDTA (pH 7.0) |
>50 Ci/g |
Every 4 weeks |
PK-NEZ147 |
Cobalt-57
Symbol: 57Co
Half Life: 271 d
Radiation Type: gamma |
Packaged in 0.1M HCL |
carrier free |
Routinrly available |
PK-NEZ022 |
Indium-111
Symbol: 111In
Half Life: 2.83 d
Radiation Types: x-ray, gamma |
As indium chloride in 0.05 M HCl.
Not for human use. |
380–415 Ci/mg |
Every Friday |
PK-NEZ304
PK-NEZ304A
PK-NEZ304B
PK-NEZ304C |
|
|
